QTXB Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 vas. 2024 @ 20:37):

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States...

Stats
Dzisiejszy wolumen	50 000.00
Średni wolumen	1 333.00
Kapitalizacja rynkowa	314 786
EPS	$-0.000780 ( 2022-11-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.400
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2012-05-25	Hirschman Shalom	Buy	150 000	Common Stock
2012-05-25	Fleming William H	Buy	300 000	Common Stock
2012-03-01	Abrams Michael S	Buy	0
2010-04-30	Pinco Robert G.	Buy	0
2010-04-30	Mooney Patrick T	Sell	0	Common Stock

INSIDER POWER
0.00
Last 43 transactions
Buy: 5 215 300 \| Sell: 826 250

QuantRx Biomedical Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

QuantRx Biomedical Finanse

Annual	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$0

FY	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$0

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.0100

FY	2020
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.0100

Financial Reports:

No articles found.

QuantRx Biomedical

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.